We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: Dilated cardiomyopathy
MedXY News
EnglishTag

Dilated cardiomyopathy

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Unraveling Mitochondrial Dysfunction in RBM20-Related Dilated Cardiomyopathy: The Role of Dysregulated Ribonucleoprotein Granules
CardiologyRBM20ribonucleoprotein granules

Unraveling Mitochondrial Dysfunction in RBM20-Related Dilated Cardiomyopathy: The Role of Dysregulated Ribonucleoprotein Granules

By MedXY|Sep 19, 2026

This article reviews novel research showing how cytoplasmic mislocalization of RBM20 impairs mitochondrial function, leading to severe dilated cardiomyopathy and highlighting distinct mechanisms between gain- and loss-of-function RBM20 vari

Genotype-Dependent Risk and Impact of Atrial Fibrillation in Dilated Cardiomyopathy: Insights from the SHaRe Registry
CardiologyLMNA
genetics

Genotype-Dependent Risk and Impact of Atrial Fibrillation in Dilated Cardiomyopathy: Insights from the SHaRe Registry

By MedXY|Sep 15, 2026

This study reveals genotype-specific differences in atrial fibrillation (AF) risk among dilated cardiomyopathy (DCM) patients, highlighting LMNA mutations as a major predictor of incident AF and its association with worse clinical outcomes,

Expanding Horizons in Dilated Cardiomyopathy: A Comprehensive Genetic Reassessment in 2024
CardiologygeneticsGene Curation

Expanding Horizons in Dilated Cardiomyopathy: A Comprehensive Genetic Reassessment in 2024

By MedXY|Sep 12, 2026

The 2024 update of the Clinical Genome Resource elucidates a rapidly expanding genetic landscape for dilated cardiomyopathy, enhancing clinical genetic interpretation with 35 genes classified as high evidence, including nine novel discoveri

Silent Killers: Unveiling the Hidden Cardiac Pathologies Behind Sudden Cardiac Death
CardiologyOccult Cardiac Diseasesudden cardiac death

Silent Killers: Unveiling the Hidden Cardiac Pathologies Behind Sudden Cardiac Death

By MedXY|Aug 18, 2026

This study reveals that two-thirds of community sudden cardiac deaths occur in individuals without diagnosed cardiac disease, with half harboring occult myocardial infarction or dilated cardiomyopathy, underscoring the need for improved det

Left Ventricular Hypertrabeculation in Dilated Cardiomyopathy: Prognostic Insights and Clinical Implications
CardiologyCardiac prognosisDilated cardiomyopathy

Left Ventricular Hypertrabeculation in Dilated Cardiomyopathy: Prognostic Insights and Clinical Implications

By MedXY|Aug 7, 2026

This study reveals that left ventricular hypertrabeculation, common in dilated cardiomyopathy, does not increase embolic risk or adverse outcomes, challenging previous concerns and guiding clinical management.

RBM20 Truncating Variants in Dilated Cardiomyopathy: Reduced Penetrance and Milder Phenotype Compared to Missense Variants
CardiologyarrhythmogenicDilated cardiomyopathy

RBM20 Truncating Variants in Dilated Cardiomyopathy: Reduced Penetrance and Milder Phenotype Compared to Missense Variants

By MedXY|Apr 28, 2026

This study highlights the role of RBM20 truncating variants in arrhythmogenic dilated cardiomyopathy, showing reduced penetrance and milder disease severity compared to pathogenic missense variants and titin truncating variants.

Precision Medicine in Dilated Cardiomyopathy: Integrating Genetic Counselling and Testing into Clinical Practice
CardiologyDilated cardiomyopathyGenetic Counselling

Precision Medicine in Dilated Cardiomyopathy: Integrating Genetic Counselling and Testing into Clinical Practice

By MedXY|Mar 20, 2026

This review explores the transition of genetic testing in dilated cardiomyopathy from family risk assessment to a central tool for clinical decision-making and personalized risk stratification.

LOXL2 Inhibition: A New Frontier in Treating LMNA-Related Dilated Cardiomyopathy
CardiologyDilated cardiomyopathyLMNA Mutation

LOXL2 Inhibition: A New Frontier in Treating LMNA-Related Dilated Cardiomyopathy

By MedXY|Mar 17, 2026

Recent research identifies LOXL2 as a primary driver of fibrosis in LMNA-mutated dilated cardiomyopathy. The study demonstrates that Simtuzumab, a LOXL2 inhibitor, effectively prevents extracellular matrix remodeling and preserves cardiac f

Precision Targeting of the Sarcomere: Danicamtiv Shows Genotype-Specific Efficacy in Dilated Cardiomyopathy
CardiologyDilated cardiomyopathyTTN

Precision Targeting of the Sarcomere: Danicamtiv Shows Genotype-Specific Efficacy in Dilated Cardiomyopathy

By MedXY|Jan 16, 2026

A Phase 2 trial demonstrates that danicamtiv, a novel cardiac myosin agonist, significantly improves left ventricular function in patients with genetic forms of dilated cardiomyopathy, particularly those with MYH7 and TTN variants, signalin

Beyond the Mutation: Uncovering the Triggers of Disease Onset in Titin-Related Dilated Cardiomyopathy
CardiologyDilated cardiomyopathy

Beyond the Mutation: Uncovering the Triggers of Disease Onset in Titin-Related Dilated Cardiomyopathy

By MedXY|Jan 3, 2026

An international multicenter study reveals that while Titin-truncating variants significantly increase cardiomyopathy risk, disease onset is heavily influenced by male sex, co-morbidities, and atrial fibrillation, while early prophylactic t

Beyond Arrhythmia: High-Risk Genotypes in Dilated Cardiomyopathy Predict Progression to Advanced Heart Failure
CardiologyarrhythmiaDilated cardiomyopathy

Beyond Arrhythmia: High-Risk Genotypes in Dilated Cardiomyopathy Predict Progression to Advanced Heart Failure

By MedXY|Jan 3, 2026

A landmark Spanish study reveals that patients with ‘arrhythmic’ genotypes in dilated cardiomyopathy face a significantly higher risk of advanced heart failure events, including heart transplantation and VAD implantation, necess

Caring for Families After a Dilated Cardiomyopathy Diagnosis: Practical Guidance from the 2025 Clinical Consensus
CardiologyDilated cardiomyopathy

Caring for Families After a Dilated Cardiomyopathy Diagnosis: Practical Guidance from the 2025 Clinical Consensus

By MedXY|Nov 29, 2025

A focused guide to modern genetic and clinical screening of relatives after a dilated cardiomyopathy diagnosis, summarizing the 2025 clinical consensus and practical steps for clinicians and families.

Sex-Specific Genetic Insights into Dilated Cardiomyopathy: The Key Role of Desmoplakin Variants
CardiologyDilated cardiomyopathyGenetic penetrance

Sex-Specific Genetic Insights into Dilated Cardiomyopathy: The Key Role of Desmoplakin Variants

By MedXY|Oct 4, 2025

Desmoplakin gene variants confer a higher risk and penetrance of dilated cardiomyopathy in females, contrasting with male-predominant risks from other genes like TTN. This discovery underscores sex-specific mechanisms in DCM susceptibility

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities